Microscopic View of Coughed-Up Mucus may be New Biomarker for Cystic Fibrosis Progression

Researchers at the Center for Nanomedicine at the Wilmer Eye Institute has been studying mucus in the lungs of cystic fibrosis patients, and their primary goal was to design inhalable therapeutic nanoparticles that cross the cystic fibrosis mucus barrier in the lung. But the work recently led the researchers to the unexpected discovery that mucus appears to change as the disease progresses; the mobility of these nanoparticles could vary widely in mucus from different patients. They will describe their findings this week during the Society of Rheology's 87th Annual Meeting, being held Oct. 11-15, 2015.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews